Variant report
Variant | nsv874890 |
---|---|
Chromosome Location | chr2:113797677-113808054 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:113793052..113795828-chr2:113797640..113799974,2 | K562 | blood: | |
2 | chr2:113798210..113800371-chr2:113830392..113832016,2 | MCF-7 | breast: | |
3 | chr2:113793052..113795716-chr2:113797814..113799974,2 | K562 | blood: | |
4 | chr2:113799300..113800125-chr2:113836934..113837726,3 | MCF-7 | breast: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IL36RN-2 | chr2:113799152-113799363 | l_1927_chr2:113799151-113802812_thyroid |
2 | lnc-IL36RN-2 | chr2:113799365-113799600 | l_1927_chr2:113799151-113802812_thyroid |
3 | lnc-IL36RN-2 | chr2:113802726-113802812 | l_1927_chr2:113799151-113802812_thyroid |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2862774 | chr2:113797677-113797678 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs150761350 | chr2:113797712-113797713 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77516439 | chr2:113797741-113797742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs528548602 | chr2:113797761-113797762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs2862775 | chr2:113797762-113797763 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs13392105 | chr2:113797766-113797767 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs549026167 | chr2:113797779-113797780 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556428559 | chr2:113797819-113797820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576993462 | chr2:113797858-113797859 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1900289 | chr2:113797875-113797876 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs574304909 | chr2:113797898-113797899 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2862776 | chr2:113797924-113797925 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs375926150 | chr2:113797938-113797939 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572208375 | chr2:113797951-113797952 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559359938 | chr2:113797962-113797963 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7557928 | chr2:113797968-113797969 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs545099470 | chr2:113798009-113798010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7567108 | chr2:113798016-113798017 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs574489019 | chr2:113798065-113798066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568378019 | chr2:113798076-113798077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139245194 | chr2:113798093-113798094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375964117 | chr2:113798110-113798111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs13418757 | chr2:113798167-113798168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs13418761 | chr2:113798178-113798179 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs372925295 | chr2:113798221-113798222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs35893082 | chr2:113798235-113798236 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs12151457 | chr2:113798241-113798242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7570058 | chr2:113798292-113798293 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs35327148 | chr2:113798300-113798301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535363531 | chr2:113798306-113798307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548277547 | chr2:113798377-113798378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs34852794 | chr2:113798378-113798379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7570159 | chr2:113798388-113798389 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs77075994 | chr2:113798432-113798433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs550699823 | chr2:113798460-113798461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569965185 | chr2:113798482-113798483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569827684 | chr2:113798500-113798501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34702403 | chr2:113798561-113798562 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs200588299 | chr2:113798568-113798569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs35734363 | chr2:113798581-113798582 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs565904553 | chr2:113798584-113798585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529228565 | chr2:113798603-113798604 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374910020 | chr2:113798604-113798605 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534763728 | chr2:113798605-113798606 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs7570483 | chr2:113798659-113798660 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs574439284 | chr2:113798662-113798663 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35098063 | chr2:113798681-113798682 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs556667585 | chr2:113798682-113798683 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374450671 | chr2:113798733-113798734 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs60553648 | chr2:113798735-113798736 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ocular motor apraxia | 21572526 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Idiopathic chronic pancreatitis | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
Maculopathy | 20981449 | CNVD |
Nephronophthisis | 22470819 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ischaemic stroke | 16980335 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Nephronophthisis | 17901113 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 17699850 | CNVD |
Ovarian cancer | 17699850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:113795800-113797800 | Enhancers | Stomach Mucosa | stomach |
2 | chr2:113796400-113798000 | Enhancers | Liver | Liver |
3 | chr2:113796600-113798000 | Enhancers | Fetal Intestine Large | intestine |
4 | chr2:113797600-113797800 | Enhancers | Fetal Intestine Small | intestine |
5 | chr2:113797600-113798600 | Weak transcription | Gastric | stomach |
6 | chr2:113797800-113799800 | Weak transcription | Stomach Mucosa | stomach |
7 | chr2:113798600-113798800 | Enhancers | Gastric | stomach |
8 | chr2:113804600-113805400 | Enhancers | Fetal Intestine Large | intestine |
9 | chr2:113804600-113805400 | Enhancers | Fetal Intestine Small | intestine |
10 | chr2:113805400-113805600 | Weak transcription | Fetal Intestine Small | intestine |
11 | chr2:113805400-113805800 | Weak transcription | Fetal Intestine Large | intestine |
12 | chr2:113805600-113806000 | Enhancers | Fetal Intestine Small | intestine |
13 | chr2:113805800-113806000 | Enhancers | Fetal Intestine Large | intestine |
14 | chr2:113806000-113808600 | Weak transcription | Fetal Intestine Large | intestine |
15 | chr2:113806000-113809000 | Weak transcription | Fetal Intestine Small | intestine |